Adverse Effects of Depolarising Neuromuscular Blocking Agents W. Jeffrey BookMark AbelJames B. Eisenkraft Review Article 04 October 2012 Pages: 331 - 349
Clinically Significant Drug Interactions with the Oral Anticoagulants Michael D. FreedmanAbiodun G. Olatidoye Review Article 04 October 2012 Pages: 381 - 394
A Risk-Benefit Assessment of Vigabatrin in the Treatment of Neurological Disorders Jayashri SrinivasanAlan Richens Review Article 04 October 2012 Pages: 395 - 405
Topical Corticosteroids and Unwanted Local Effects Moira MoriNicola PimpinelliBenvenuto Giannotti Review Article 04 October 2012 Pages: 406 - 412